Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) PT at $110.71

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given an average rating of “Moderate Buy” by the fourteen research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $110.71.

HQY has been the subject of a number of research analyst reports. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. JMP Securities upped their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Barrington Research lifted their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. Finally, Mizuho initiated coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,289 shares of company stock worth $3,355,718 in the last 90 days. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HQY. First Horizon Advisors Inc. boosted its position in HealthEquity by 50.7% during the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock valued at $107,000 after purchasing an additional 375 shares during the last quarter. Arcadia Investment Management Corp MI acquired a new stake in HealthEquity in the 4th quarter valued at about $26,000. Handelsbanken Fonder AB grew its holdings in HealthEquity by 8.2% during the fourth quarter. Handelsbanken Fonder AB now owns 22,316 shares of the company’s stock worth $2,141,000 after purchasing an additional 1,700 shares during the period. Convergence Investment Partners LLC acquired a new position in HealthEquity during the fourth quarter worth approximately $217,000. Finally, New York State Common Retirement Fund raised its stake in HealthEquity by 142.6% in the fourth quarter. New York State Common Retirement Fund now owns 102,200 shares of the company’s stock valued at $9,806,000 after buying an additional 60,077 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Down 0.1 %

HQY opened at $110.31 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market cap of $9.56 billion, a price-to-earnings ratio of 101.20, a PEG ratio of 1.94 and a beta of 0.54. HealthEquity has a one year low of $65.01 and a one year high of $112.53. The business’s fifty day moving average is $100.22 and its two-hundred day moving average is $88.75.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm posted $0.40 EPS. Analysts anticipate that HealthEquity will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.